Tumor volume impact on patient prognosis with locally advanced non-small-cell lung cancer treated by three-dimensional conformal radiation therapy

MA Tieying,YUE Li,WANG Weidong,HUO Zhifeng
DOI: https://doi.org/10.3969/j.issn.1674-4721.2012.13.027
2012-01-01
Abstract:Objective To evaluate tumor volume impact on patient prognosis with stageⅢ A and stageⅢB NSCLC treated by three dimensional confornlal radiation therapy (3D CRT).Methods Between 2002 and 2009,64 cases were analyzed.23 patients were treated with radiotherapy alone;23 patients were treated with concurrent chemoradiotherapy;18 patients were treated with sequential chemoradiotherapy.The median radiotherapy dose were 60 (range 50-78) Gy.Results For the whole group,median survival time was 18.6 months.1,3,5 year overall survival rates (OS) were 69.7%,22.7%,10.4%;1,3,5-year cancer specific survival rates (CSS) were 73.8%,29.7%,15.8%.In univariate analysis,the following variables were significantly associated with OS and CSS:elected node irradiation,total dose,tumor volume and clinical tumor response.In multivariate analysis,tumor volume and clinical tumor response were the independent factors on OS and CSS.80 cm3 of tumor volume was selected as the threshold which optimally predict the prognosis.Conclusion Tumor volume of 80 cm3 is the threshold which optimally predicts the prognosis for patients with StageⅢ A and stageⅢB NSCLC patients who are treated by 3D CRT.Tumor volume and clinical tumor response are independent factors on OS and CSS.
What problem does this paper attempt to address?